Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Chubb
Fuji
Colorcon
Fish and Richardson
Cantor Fitzgerald
Queensland Health
Teva
Moodys

Generated: May 23, 2018

DrugPatentWatch Database Preview

LINCOMYCIN Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Lincomycin, and what generic alternatives are available?

Lincomycin is a drug marketed by X-gen Pharms Inc and Watson Labs and is included in two NDAs.

The generic ingredient in LINCOMYCIN is lincomycin hydrochloride. There are eleven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the lincomycin hydrochloride profile page.
Drug patent expirations by year for LINCOMYCIN
Medical Subject Heading (MeSH) Categories for LINCOMYCIN
Synonyms for LINCOMYCIN
(2S,4R)-N-((1R,2R)-2-hydroxy-1-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)-tetrahydro-2H-pyran-2-yl)propyl)-1-methyl-4-propylpyrrolidine-2-carboxamide
(2S,4R)-N-((1S)-2-hydroxy-1-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)-tetrahydro-2H-pyran-2-yl)propyl)-1-methyl-4-propylpyrrolidine-2-carboxamide
(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylsulfanyl)oxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide
(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyl-tetrahydropyran-2-yl]propyl]-1-methyl-4-propyl-pyrrolidine-2-carboxamide
(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide
1-Methyl-4-propyl-pyrrolidine-2-carboxylic acid [2-hydroxy-1-(3,4,5-trihydroxy-6-methylsulfanyl-tetrahydro-pyran-2-yl)-propyl]-amide
12768-69-3
154-21-2
16977-76-7
3QB
54L212
7179-49-9 (mono-hydrochloride, hemi.hydrate)
859-18-7 (mono-hydrochloride)
AB01275426-01
AB1009493
AC1MHD7X
AK481281
AKOS015951392
BDBM50335522
BOD072YW0F
BRD-K49384696-003-01-9
BRN 0707677
C06812
C18H34N2O6S
CCG-208231
CHEBI:6472
CHEMBL1447
Cillimycin
D-Erythro-.alpha.-D-gluco-octopyranoside, methyl 6,8-dideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-
D-erythro-alpha-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-((((2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-
D-erythro-alpha-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, (2S-trans)-
D-erythro-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-, trans-alpha-
D00223
DB01627
DTXSID3023215
EINECS 205-824-6
FT-0696547
HMS2089A13
HSDB 3109
Jiemycin
Lincocin
Lincolcina
Lincolnensin
Lincomicina
Lincomicina [INN-Spanish]
Lincomycin (USAN/INN)
Lincomycin [USAN:INN:BAN]
Lincomycin A
LINCOMYCIN HCL
Lincomycin hydrochloride
Lincomycin, (2S-cis)-Isomer
Lincomycin, Antibiotic for Culture Media Use Only
Lincomycine
Lincomycine [French]
Lincomycine [INN-French]
Lincomycinum
Lincomycinum [INN-Latin]
LS-174532
MCULE-4676929559
medoglycine
methyl 6,8-dideoxy-6-({[(2S,4R)-1-methyl-4-propylpyrrolidin-2-yl]carbonyl}amino)-1-thio-D-erythro-alpha-D-galacto-octopyranoside
Methyl 6,8-dideoxy-6-(1-methyl-4-propyl-2-pyrrolidinecarboxamido)-1-thio-D-erythro-D-galacto-octopyranoside (alpha-form)
Methyl 6,8-dideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-D-erythro-|A-D-glucooctopyranoside
methyl 6,8-dideoxy-6-{[(4R)-1-methyl-4-propyl-L-prolyl]amino}-1-thio-D-erythro-alpha-D-galacto-octopyranoside
Methyl 6,8-dideoxy-6-trans-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-D-erythro-alpha-D-galacto-octopyranoside
MolPort-002-507-379
NE39438
NSC-70731
NSC70731
OJMMVQQUTAEWLP-KIDUDLJLSA-N
SC-71087
SCHEMBL4010
SMP1_000178
STOCK1N-50613
U 10,149A
U-10,149
U-10149
UNII-BOD072YW0F
W-109518
Z1665194511
ZINC3982483

US Patents and Regulatory Information for LINCOMYCIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
X-gen Pharms Inc LINCOMYCIN lincomycin hydrochloride INJECTABLE;INJECTION 201746-001 Jun 4, 2015 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs LINCOMYCIN HYDROCHLORIDE lincomycin hydrochloride INJECTABLE;INJECTION 063180-001 Apr 16, 1991 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Mallinckrodt
Cantor Fitzgerald
Healthtrust
Baxter
Moodys
Colorcon
Boehringer Ingelheim
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.